Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity

Tara Vanderweyde(Boston University), Daniel J. Apicco(Boston University), Katherine Youmans-Kidder(Boston University), Peter E.A. Ash(Boston University), Casey Cook(Mayo Clinic in Florida), Edroaldo Lummertz da Rocha(Mayo Clinic), Karen Jansen‐West(Mayo Clinic in Florida), Alissa A. Frame(Boston University), Allison Citro(Boston University), John Leszyk(University of Massachusetts Chan Medical School), Pavel Ivanov(Brigham and Women's Hospital), Jose F. Abisambra(University of Kentucky), Martín Steffen(Boston University), Hu Li(Mayo Clinic), Leonard Petrucelli(Mayo Clinic in Florida), Benjamin Wolozin(Boston University)
Cell Reports
May 1, 2016
Cited by 346Open Access
Full Text

Abstract

Dendritic mislocalization of microtubule associated protein tau is a hallmark of tauopathies, but the role of dendritic tau is unknown. We now report that tau interacts with the RNA-binding protein (RBP) TIA1 in brain tissue, and we present the brain-protein interactome network for TIA1. Analysis of the TIA1 interactome in brain tissue from wild-type (WT) and tau knockout mice demonstrates that tau is required for normal interactions of TIA1 with proteins linked to RNA metabolism, including ribosomal proteins and RBPs. Expression studies show that tau regulates the distribution of TIA1, and tau accelerates stress granule (SG) formation. Conversely, TIA1 knockdown or knockout inhibits tau misfolding and associated toxicity in cultured hippocampal neurons, while overexpressing TIA1 induces tau misfolding and stimulates neurodegeneration. Pharmacological interventions that prevent SG formation also inhibit tau pathophysiology. These studies suggest that the pathophysiology of tauopathy requires an intimate interaction with RNA-binding proteins.


Related Papers

No related papers found

Powered by citation graph analysis